These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31610656)

  • 1. Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment.
    Ruan S; Xie R; Qin L; Yu M; Xiao W; Hu C; Yu W; Qian Z; Ouyang L; He Q; Gao H
    Nano Lett; 2019 Nov; 19(11):8318-8332. PubMed ID: 31610656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer Photochemotherapy.
    Emami F; Banstola A; Vatanara A; Lee S; Kim JO; Jeong JH; Yook S
    Mol Pharm; 2019 Mar; 16(3):1184-1199. PubMed ID: 30698975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells.
    Miyazaki T; Ishikawa E; Matsuda M; Sugii N; Kohzuki H; Akutsu H; Sakamoto N; Takano S; Matsumura A
    Brain Tumor Pathol; 2020 Apr; 37(2):41-49. PubMed ID: 31980975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp70-Targeting and Size-Tunable Nanoparticles Combine with PD-1 Checkpoint Blockade to Treat Glioma.
    Xie R; Wang Y; Tong F; Yang W; Lei T; Du Y; Wang X; Yang Z; Gong T; Shevtsov M; Gao H
    Small; 2023 Sep; 19(37):e2300570. PubMed ID: 37222118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Checkpoint Blockade in Combination With Doxorubicin Augments Tumor Cell Apoptosis in Osteosarcoma.
    Wang J; Hu C; Wang J; Shen Y; Bao Q; He F; Wang H; Gong L; Liu Z; Hu F; Liang J; Zhou Q; Wei L; Wen J; Zhang W
    J Immunother; 2019; 42(9):321-330. PubMed ID: 31219973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
    Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
    Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy.
    Li M; Zhao D; Yan J; Fu X; Li F; Liu G; Fan Y; Liang Y; Zhang X
    ACS Nano; 2024 May; 18(20):12870-12884. PubMed ID: 38727063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furin-instructed aggregated gold nanoparticles for re-educating tumor associated macrophages and overcoming breast cancer chemoresistance.
    Xie R; Ruan S; Liu J; Qin L; Yang C; Tong F; Lei T; Shevtsov M; Gao H; Qin Y
    Biomaterials; 2021 Aug; 275():120891. PubMed ID: 34051669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation.
    Ruan S; Hu C; Tang X; Cun X; Xiao W; Shi K; He Q; Gao H
    ACS Nano; 2016 Nov; 10(11):10086-10098. PubMed ID: 27934068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced glioma therapy by synergistic inhibition of autophagy and tyrosine kinase activity.
    Wang X; Qiu Y; Yu Q; Li H; Chen X; Li M; Long Y; Liu Y; Lu L; Tang J; Zhang Z; He Q
    Int J Pharm; 2018 Jan; 536(1):1-10. PubMed ID: 28887220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma.
    Zhang P; Miska J; Lee-Chang C; Rashidi A; Panek WK; An S; Zannikou M; Lopez-Rosas A; Han Y; Xiao T; Pituch KC; Kanojia D; Balyasnikova IV; Lesniak MS
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23714-23723. PubMed ID: 31712430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases.
    Mu X; Zhang M; Wei A; Yin F; Wang Y; Hu K; Jiang J
    Nanoscale; 2021 May; 13(19):8998-9008. PubMed ID: 33973580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine.
    Kim H; Khanna V; Kucaba TA; Zhang W; Ferguson DM; Griffith TS; Panyam J
    Mol Pharm; 2019 Mar; 16(3):1200-1210. PubMed ID: 30620878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy.
    Wan WJ; Qu CX; Zhou YJ; Zhang L; Chen MT; Liu Y; You BG; Li F; Wang DD; Zhang XN
    Int J Pharm; 2019 Jul; 566():731-744. PubMed ID: 31212055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy.
    Cheng Y; Wang C; Wang H; Zhang Z; Yang X; Dong Y; Ma L; Luo J
    BMC Med; 2022 Oct; 20(1):411. PubMed ID: 36303207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma.
    Zhu S; Lv X; Zhang X; Li T; Zang G; Yang N; Wang X; Wu J; Chen W; Liu YJ; Chen J
    Int J Cancer; 2019 Jun; 144(11):2867-2879. PubMed ID: 30565657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of ibrutinib and hydroxychloroquine by albumin nanoparticles for enhanced chemotherapy of glioma.
    Yang Z; Du Y; Lei L; Xia X; Wang X; Tong F; Li Y; Gao H
    Int J Pharm; 2023 Jan; 630():122436. PubMed ID: 36436742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.